193 related articles for article (PubMed ID: 34964899)
1. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.
Knudsen AM; Halle B; Cédile O; Burton M; Baun C; Thisgaard H; Anand A; Hubert C; Thomassen M; Michaelsen SR; Olsen BB; Dahlrot RH; Bjerkvig R; Lathia JD; Kristensen BW
Neuro Oncol; 2022 Jul; 24(7):1074-1087. PubMed ID: 34964899
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
Wu H; Guo C; Wang C; Xu J; Zheng S; Duan J; Li Y; Bai H; Xu Q; Ning F; Wang F; Yang Q
Cancer Sci; 2023 Jun; 114(6):2609-2621. PubMed ID: 36853018
[TBL] [Abstract][Full Text] [Related]
4. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
Grzelinski M; Bader N; Czubayko F; Aigner A
Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
[TBL] [Abstract][Full Text] [Related]
5. Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy.
Xie XP; Laks DR; Sun D; Ganbold M; Wang Z; Pedraza AM; Bale T; Tabar V; Brennan C; Zhou X; Parada LF
Dev Cell; 2022 Jan; 57(1):32-46.e8. PubMed ID: 35016005
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
[TBL] [Abstract][Full Text] [Related]
7. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
[TBL] [Abstract][Full Text] [Related]
8. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
[TBL] [Abstract][Full Text] [Related]
10. Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.
Lu-Emerson C; Snuderl M; Kirkpatrick ND; Goveia J; Davidson C; Huang Y; Riedemann L; Taylor J; Ivy P; Duda DG; Ancukiewicz M; Plotkin SR; Chi AS; Gerstner ER; Eichler AF; Dietrich J; Stemmer-Rachamimov AO; Batchelor TT; Jain RK
Neuro Oncol; 2013 Aug; 15(8):1079-87. PubMed ID: 23828240
[TBL] [Abstract][Full Text] [Related]
11. Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells.
Zhang L; Laaniste L; Jiang Y; Alafuzoff I; Uhrbom L; Dimberg A
Oncotarget; 2016 Dec; 7(49):80382-80390. PubMed ID: 27806344
[TBL] [Abstract][Full Text] [Related]
12. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
[TBL] [Abstract][Full Text] [Related]
13. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
14. ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
Wang F; Wang AY; Chesnelong C; Yang Y; Nabbi A; Thalappilly S; Alekseev V; Riabowol K
Oncogene; 2018 Jan; 37(3):286-301. PubMed ID: 28925404
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells.
Podergajs N; Motaln H; Rajčević U; Verbovšek U; Koršič M; Obad N; Espedal H; Vittori M; Herold-Mende C; Miletic H; Bjerkvig R; Turnšek TL
Oncotarget; 2016 Jan; 7(1):593-609. PubMed ID: 26573230
[TBL] [Abstract][Full Text] [Related]
16. PC3-Secreted Microprotein Is Expressed in Glioblastoma Stem-Like Cells and Human Glioma Tissues.
Maruyama M; Nakano Y; Nishimura T; Iwata R; Matsuda S; Hayashi M; Nakai Y; Nonaka M; Sugimoto T
Biol Pharm Bull; 2021 Jul; 44(7):910-919. PubMed ID: 33896885
[TBL] [Abstract][Full Text] [Related]
17. The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.
Gravina GL; Mancini A; Colapietro A; Vitale F; Vetuschi A; Pompili S; Rossi G; Marampon F; Richardson PJ; Patient L; Patient L; Burbidge S; Festuccia C
Tumour Biol; 2017 Jun; 39(6):1010428317695528. PubMed ID: 28639900
[TBL] [Abstract][Full Text] [Related]
18. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth.
Shi Y; Ping YF; Zhou W; He ZC; Chen C; Bian BS; Zhang L; Chen L; Lan X; Zhang XC; Zhou K; Liu Q; Long H; Fu TW; Zhang XN; Cao MF; Huang Z; Fang X; Wang X; Feng H; Yao XH; Yu SC; Cui YH; Zhang X; Rich JN; Bao S; Bian XW
Nat Commun; 2017 Jun; 8():15080. PubMed ID: 28569747
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy.
Urbantat RM; Jelgersma C; Brandenburg S; Nieminen-Kelhä M; Kremenetskaia I; Zollfrank J; Mueller S; Rubarth K; Koch A; Vajkoczy P; Acker G
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681839
[TBL] [Abstract][Full Text] [Related]
20. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
